Qiagen (QGEN) Cash from Financing Activities (2010 - 2026)
Qiagen's (QGEN) quarterly Cash from Financing Activities came in at -$503.7 million in Q1 2026, down 75.67% year-on-year from -$2.1 billion in Q1 2025, and down 5.37% quarter-over-quarter from -$478.0 million in Q4 2025.
Qiagen (QGEN) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Qiagen has disclosed Cash from Financing Activities across 16 years of filings, most recently posting -$503.7 million for Q1 2026.
- Cash from Financing Activities for Q1 2026 came in at -$503.7 million, down 75.67% year-over-year; the trailing twelve-month figure through Mar 2026 was -$395.6 million (up 5.16% YoY), and the FY2025 annual result was -$179.0 million, up 57.68% from the prior year.
- Cash from Financing Activities came in at -$503.7 million for Q1 2026 at Qiagen, down from -$478.0 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $614.1 million in Q3 2025 to a low of -$503.7 million in Q1 2026.
- The 5-year median for Cash from Financing Activities is -$28.0 million (2025), against an average of -$73.2 million.
- Across the five-year window, Cash from Financing Activities surged 983.74% in 2022 and plunged 6012.5% in 2024, its largest moves.
- Qiagen's Cash from Financing Activities stood at -$126.0 million in 2022, then jumped by 93.65% to -$8.0 million in 2023, then slumped by 6012.5% to -$489.0 million in 2024, then gained by 2.25% to -$478.0 million in 2025, then retreated by 5.37% to -$503.7 million in 2026.
- The last three Cash from Financing Activities figures came in at -$503.7 million (Q1 2026), -$478.0 million (Q4 2025), and $614.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -213.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 1.09 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 46.00 Mn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | -211.43 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | -144.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 3.76 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -433.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | -251.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -114.33 Mn |
| 10 | Qiagen | 8.54 Bn | 7.44 Bn | - | -503.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -503.66 Mn |
| Mar 31, 2026 | -503.66 Mn |
| Dec 31, 2025 | -478.00 Mn |
| Dec 31, 2025 | -478.00 Mn |
| Sep 30, 2025 | 614.07 Mn |
| Sep 30, 2025 | 614.07 Mn |
| Jun 30, 2025 | -28.00 Mn |
| Jun 30, 2025 | -28.00 Mn |
| Mar 31, 2025 | -286.70 Mn |
| Mar 31, 2025 | -286.70 Mn |
| Dec 31, 2024 | -489.00 Mn |
| Dec 31, 2024 | -489.00 Mn |
| Sep 30, 2024 | 485.58 Mn |
| Sep 30, 2024 | 485.58 Mn |
| Jun 30, 2024 | -127.00 Mn |
| Jun 30, 2024 | -127.00 Mn |
| Mar 31, 2024 | -292.10 Mn |
| Mar 31, 2024 | -292.10 Mn |
| Dec 31, 2023 | -8.00 Mn |
| Dec 31, 2023 | -8.00 Mn |